Topanyusol 10% Injection
L-Isoleucine 0.56g · L-Leucine 1.25g +16 more
Prescription medication · Combination
Huons Co., Ltd.
MFDS item code 199702329 · Notified 1997.10.23 · Insurance code 670608841
Improvement of nutritional status through amino acid supplementation (hypoproteinemia, before and after surgery, etc.)
The supply of amino acids during hypoproteinemia, malnutrition, and conditions such as before and after surgery is very important for helping the patient's protein supply, recovery of strength, and maintenance of physical function. In these cases, amino acid supplementation improves nutritional imbalance and supports rapid recovery. Therefore, it is used to supply amino acids in cases of hypoproteinemia and malnutrition, as well as before and after surgery.
○For peripheral intravenous administration: -Adults: Slowly administer 200~400 mL by intravenous drip infusion per dose. -Infusion rate: Based on 200 mL over 120 minutes (approximately 25 drops per minute), an amino acid amount of around 10 g per hour is desirable for utilization in the body. Infuse slowly in elderly patients and patients with severe illness. ○For central venous administration: Continuously infuse 400~800 mL per day into a central vein according to the high-calorie infusion regimen. For efficient amino acid utilization in the body, it is preferable to administer this medicine concurrently with a carbohydrate infusion. In elderly patients and patients with burns who have high protein requirements, adjust the dose and infusion rate appropriately before administration.
Infuse slowly in children. In children, adjust the dose and infusion rate appropriately before administration.
This medication must be used strictly according to a doctor's instructions, and using it arbitrarily can be dangerous. This medication should not be used in patients with hepatic encephalopathy or those at risk of hepatic encephalopathy, severe renal impairment, or high blood nitrogen levels. Additionally, it should not be administered to patients with nitrogen metabolism issues, severe heart failure or pulmonary edema, and those with extremely low or absent urine output. In cases where sodium and chloride ions are included, it is crucial not to administer this to patients with hypernatremia, hyperchloremia, or alkalosis. Patients with a history of myocardial infarction or current heart disease must consult a doctor before using this medication. Careful administration is advised for patients with specific metabolic abnormalities such as severe acidosis, congestive heart failure, edema due to sodium retention, and hyperkalemia, as well as caution is needed in cases of reduced liver or kidney function. This medication contains sodium bisulfite, which can cause severe allergic reactions or asthma attacks in patients allergic to sulfites or asthmatics, thus caution is necessary. During use, abnormal reactions such as skin rash, nausea, vomiting, palpitations, and high blood pressure may occur, and if such symptoms appear, administration should be discontinued immediately, and the physician should be notified. Rapid administration in large amounts can result in acidosis, so it is important to regulate the rate and volume of administration. This medication can cause electrolyte imbalances, so electrolyte status should be frequently monitored, especially with large doses. Diabetic patients should measure their blood glucose levels frequently during use, and patients with a history of kidney or lung diseases, or heart diseases should be carefully administered to reduce the risk of fluid overload. There may be drug interactions, so it is best to consult a specialist when using it with tetracycline antibiotics. Pregnant women should only use this medication when the therapeutic benefits outweigh the risks, as its safety has not been established. In children, liver function may be immature, thus dosing should be adjusted to lower concentrations, and blood ammonia levels should be frequently monitored. In the elderly, caution is necessary due to decreased physiological function, and the administration rate and dosage should be adjusted accordingly. During administration, electrolyte balance must be maintained, ensure the infusion is not rapid, and adjust the medication according to body temperature. Preparation and management of the infusion solution must be carried out under strict aseptic conditions, and the solution should be checked for color changes or precipitates before use. When storing, do not open the packaging, and do not use it if discoloration or leakage occurs, and it should be stored under appropriate temperature and conditions for safety.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to avoid contact with air, preferably at room temperature. Avoid extremely hot or cold places, and store it in a cool place away from direct sunlight.
A colorless, transparent injection solution in a colorless, transparent glass vial sealed with a rubber stopper for infusion.
500 mL / vial
Even with the same ingredient, strength, dosage form and how it is taken can differ.
L-Isoleucine 0.56g · L-Leucine 1.25g +16 more
Prescription medication · Combination
Huons Co., Ltd.
L-Isoleucine 0.91g · L-Leucine 1.29g +16 more
Injections · Prescription medication · Combination
Daehan Pharmaceutical Co., Ltd.
L-Isoleucine 8g · L-Leucine 14g +16 more
Injections · Prescription medication · Combination
Samsung Pharmaceutical Co., Ltd.
L-Isoleucine 0.56g · L-Leucine 1.25g +16 more
Injections · Prescription medication · Combination
Daehan Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.